Alexander Lachmann | Mount Sinai

Biography

Research Topics

Bioinformatics, Biomedical Informatics, Biomedical Sciences, Biostatistics, Computational Biology, Drug Design and Discovery, Gene Regulation, Genomics

Education

Diplom, University Aachen

PhD, Columbia University

Publications

47

Publications

Selected Publications

PrismEXP: gene annotation prediction from stratified gene-gene co-expression matrices. Alexander Lachmann, Kaeli A. Rizzo, Alon Bartal, Minji Jeon, Daniel J.B. Clarke, Avi Ma’ayan. PeerJ

lncHUB2: aggregated and inferred knowledge about human and mouse lncRNAs. Giacomo B. Marino, Megan L. Wojciechowicz, Daniel J.B. Clarke, Maxim V. Kuleshov, Zhuorui Xie, Minji Jeon, Alexander Lachmann, Avi Ma'ayan. Database : the journal of biological databases and curation

DrugShot: querying biomedical search terms to retrieve prioritized lists of small molecules. Eryk Kropiwnicki, Alexander Lachmann, Daniel J.B. Clarke, Zhuorui Xie, Kathleen M. Jagodnik, Avi Ma’ayan. BMC Bioinformatics

View All Publications

Office Locations

Annenberg Building Floor 19 Room 19-60C

1468 Madison Ave

New York, NY 10029

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Lachmann during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Lachmann during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.